Skip to content
Preprint · CC-BY via OpenAlex

Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes

Juanhong Liu, Yuanlong Ge, Shu Wu, Delin Ma, Weijie Xu, Ye Zhang, Yan Yang

Aging · 2019 · ▲ 28 citations

Abstract

Telomere(definition) length and telomere shortening rate (TSR) are accepted indicators of aging in cross-sectional population studies. This study aimed to investigate the potential influence of common antidiabetic agents on telomere length and TSR in patients with type 2 diabetes mellitus (T2DM). Leukocyte telomere length was measured through terminal restriction fragment analysis, and TSR was calculated in 388 T2DM patients. Depending on whether or not they received antidiabetic medication, patients were first divided into a treatment group and a nontreatment group. Treated patients were further subdivided into an acarbose-free group (patients taking antidiabetic agents without acarbose) and an acarbose group (patients using acarbose for more than 3 months). Results showed that untreated patients had higher TSRs than patients on antidiabetic drugs. Interestingly, patients in the acarbose group had significantly higher TSRs than patients in the acarbose-free group. Compared to the nontreatment group, the acarbose group showed better glycemic control of HbA1c, but the TSR was also higher. Our results suggest that antidiabetic treatments without acarbose can slow aging. By contrast, acarbose may accelerate biological aging in patients with T2DM, independently of glycemic control.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.18632/aging.101781
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Liu, J., Ge, Y., Wu, S., Ma, D., Xu, W., Zhang, Y., &amp; Yang, Y. (2019). Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes. <em>Aging</em>. https://doi.org/10.18632/aging.101781
Vancouver
Liu J, Ge Y, Wu S, Ma D, Xu W, Zhang Y, et al. Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes. Aging. 2019. doi:10.18632/aging.101781.
BibTeX
@unpublished{juanhong2019Associ, title = {Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes}, author = {Juanhong Liu and Yuanlong Ge and Shu Wu and Delin Ma and Weijie Xu and Ye Zhang and Yan Yang}, journal = {Aging}, year = {2019}, doi = {10.18632/aging.101781}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings